COMPLICATED URINARY TRACT INFECTION
Clinical trials for COMPLICATED URINARY TRACT INFECTION explained in plain language.
Never miss a new study
Get alerted when new COMPLICATED URINARY TRACT INFECTION trials appear
Sign up with your email to follow new studies for COMPLICATED URINARY TRACT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibiotic trial aims to treat tough kidney infections in kids
Disease control Recruiting nowThis study is testing an antibiotic called Vabomere in children aged 3 months to 12 years who have complicated urinary tract infections, including kidney infections. The goal is to see if the drug is safe and how the body processes it. About 66 children will receive the medicine …
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Phase: PHASE2 • Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could one IV dose be enough? new trial aims to cut hospital stays for kids with UTIs
Symptom relief Recruiting nowThis study compares two treatment plans for children with complicated urinary tract infections (UTIs). One group gets a single IV antibiotic dose followed by two days of oral antibiotics, while the other gets three daily IV doses. The goal is to see if the shorter IV course works…
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated May 17, 2026 09:03 UTC
-
New antibiotic zavicefta under Real-World watch in korea
Knowledge-focused Recruiting nowThis study tracks the safety and effectiveness of Zavicefta, an antibiotic already approved in Korea, in 600 patients with serious abdominal, urinary tract, or hospital-acquired lung infections. Researchers will record any side effects and how well the drug works. The goal is to …
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC